New Mexico announces measles outbreak in a county detention facility
The Luna County Detention Center, located in the southwest New Mexico city of Deming, houses about 400 incarcerated people and has 100 staff members. State health officials say they are determining the vaccination status of people being held at the facility and are providing testing kits and equipment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
an hour ago
- Forbes
This Supreme Court Health Insurance Ruling Affects 150 Million Americans—What This Means for Cancer Patients
Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. In a critical victory for patients on June 27th, the Supreme Court has determined that health insurance plans under the Affordable Care Act (ACA), also known as Obamacare, must continue to fully cover preventative services, including cancer screenings, HIV prevention medication, and mental health counseling, without co-pays or deductibles. An estimated 150 million Americans will benefit from the ruling, according to the O'Neill Institute at Georgetown Law. These preventative treatments have been available to Americans under the ACA since the law went into effect over a decade ago—and advocates argued that eliminating access could pose significant health care risks to those who rely on them the most. Before the ruling, a New Orleans lower court had deemed the ACA's preventative services mandate unconstitutional, arguing that the members of the U.S. Preventive Services Task Force were not validly appointed. Had the decision stood, insurers could impose cost-sharing on screenings, meaning patients could have been forced to pay hundreds or thousands of dollars in out-of-pocket costs, potentially leading to skipped exams and life-threatening delayed diagnoses. A 2024 report published in Health Services Research revealed that with the implementation of ACA, patients receiving cancer treatment increased by 6.2%, with a noted sharp increase in 2016 when Medicaid expansion took effect in Pennsylvania. Another progress report by the American Association for Cancer Research found that the ACA shrunk other coverage gaps, including the rate of delayed surgery, which dropped from 9.8% to 8.4% after Medicaid expansion for patients belonging to ethnic minority groups. Although this ruling heavily impacts cancer screenings, it also preserves coverage for other preventative care like cholesterol, blood pressure checks, lung cancer screenings, HIV prevention (PrEP), medications to prevent breast cancer, and immunizations. Patients who face multiple health risks should use a holistic approach and capitalize on ACA's benefits for a robust safety net. Consumers should: Maintain regular screenings: The Affordable Care Act continues to fully cover routine cancer screenings at no cost. Make use of annual mammograms, colonoscopies, or lung-cancer risk to catch anything at an early stage. The Affordable Care Act continues to fully cover routine cancer screenings at no cost. Make use of annual mammograms, colonoscopies, or lung-cancer risk to catch anything at an early stage. Watch for policy changes: Though coverage remains solid for now, future reforms or appointee decisions under Robert F. Kennedy Jr., Secretary of Health and Human Services, could mean changes in the future. Stay alert to federal health updates. The Supreme Court's ruling is a significant win for cancer patients and public health. By guaranteeing continued access to free preventative care, it helps improve early detection, reduce treatment costs and barriers, and save lives. However, vigilance is key. Patients should stay aware of administrative changes that might shift the policy basis of covered services in the future.
Fox News
an hour ago
- Fox News
Just one surgical procedure is more popular than breast augmentation: See the report
Americans continue to invest in their aesthetic health. A new report from the American Society of Plastic Surgeons (ASPS) shows steady growth in cosmetic procedures last year, particularly in body contouring and minimally invasive treatments. The report's data, detailed below, reveals where people are spending their money. Of the nearly 1.6 million cosmetic surgical procedures performed in 2024, liposuction and breast augmentation topped the list. "Surgical procedures grew by 1% from 2023," ASPS President Dr. Scott Hollenbeck, a general plastic surgeon based in Charlottesville, Virginia, shared in a press release, noting that body contouring procedures saw the highest increase. Thigh and buttock lifts were up 3%, while arm and neck lifts rose 2%. Surgeons believe this may reflect the rising use of GLP-1 weight-loss medications, like Ozempic and Wegovy, which can lead to sagging skin. Minimally invasive procedures continue to dominate the aesthetic landscape, with over 28.5 million performed last year. The top five listed below led the pack. "These treatments remain strong due to their affordability and low downtime," said ASPS member surgeon Dr. Kristy Hamilton, a general plastic surgeon based in Houston, Texas, in the release. "Despite so-called 'filler fatigue,' HA fillers continue to top the list — when done naturally, they're extremely effective," she added. For the first time, ASPS tracked the use of GLP-1 weight-loss medications, noting that over 837,000 prescriptions were written by ASPS surgeons in 2024. Of those patients, 20% had already undergone surgery, 39% were considering surgery and 41% were exploring non-surgical options, the report shared. "These medications are helping patients reach a healthy weight before surgery," Dr. Heather Faulkner, a cosmetic plastic surgeon based in Atlanta, Goergia, said in the release. "But they're not substitutes — you must be near your goal weight before considering procedures like tummy tucks or lifts." A number of factors could contribute to the high demand for cosmetic procedures, according to experts. "Maybe it's greater exposure through social media or a general decrease in taboos," said Hollenbeck. "Either way, patients are prioritizing their aesthetic health." Surgeons agree that aesthetic procedures go beyond vanity, suggesting they are about feeling strong, confident and healthy. Many also see them as part of a holistic self-care routine, alongside diet, fitness and mental well-being. "Patients are prioritizing their aesthetic health." Social media is also helping to normalize aesthetic care, making procedures more accessible and less stigmatized, the report stated. Patients now openly discuss their experiences and are seeking natural, subtle enhancements, not exaggerated results. "There's a trend toward the 'ballerina body,'" Dr. Michele Shermak, a general plastic surgeon based in Baltimore, Maryland, said in the report. "Smaller implants, lifted silhouettes — women want to look refined, not overdone." Cosmetic procedures weren't the only area of growth. Over one million reconstructive surgeries were performed in 2024, including the most common ones listed below. "Plastic surgeons are also innovators in complex wound care," said Dr. Sara Dickie, general plastic surgeon based in Morton Grove, Illinois, according to the report. "Whether it's trauma, dog bites or tumor removal, our work goes beyond aesthetics." For more Health articles, visit While trends may come and go, ASPS emphasizes that safety should always come first, recommending that procedures are performed by board-certified plastic surgeons with the appropriate training and experience. "Patients want to look and feel their best," Hollenbeck added. "And when done right, aesthetic care can support mental and physical well-being in truly meaningful ways."
Medscape
an hour ago
- Medscape
Fast Five Quiz: The Psychosocial Burden of Psoriasis
The relationship between psoriasis and psychosocial symptoms tends to be a cyclical one. Psychological stressors can exacerbate the disease through overactivation of the hypothalamic-pituitary-adrenal axis and increased release of pro-inflammatory cytokines. Conversely, the cutaneous inflammatory response can cause body disfigurement, stigmatization, and ultimately anxiety and depression. What do you know about the psychosocial burden of psoriasis? Test your knowledge with this quick quiz. As patients with psoriasis experience a relapsing course, over time they often face a lower quality of life owing to their symptoms, social stigmas, and impacted self-esteem. For example, a review that evaluated the psychological comorbidities associated with this condition reported that patients with psoriasis who have visible psoriatic lesions face a significant negative impact on their quality of life. Further, Dermatology Life Quality Index (DLQI) and Health-Related Quality of Life (HRQOL) scores can be influenced by both lesion location and severity; increased Psoriasis Area and Severity Index scores have been linked to higher DLQI scores as well, which indicates that "as disease severity worsens, so does the overall impact on quality of life." Patients can experience any form of psychological and social distress as a result, not just anxiety. Although depression in psoriasis is common, the psychosocial impact of the disease has not been mainly linked with fear of developing psoriatic arthritis. Learn more about the prognosis of psoriasis. In patients with psoriasis, female sex has been identified as a risk factor for depression in this population. A systematic review exploring the burden of depression in psoriasis reported a higher overall prevalence of depression in females over males. This is consistent with other recent data; however, male patients with psoriasis still seem to have an increased prevalence of depression compared with males without psoriasis. Ultimately, current data point to the fact that the prevalence of depression is higher among all patients with psoriasis, but female patients with skin disease appear to be at greater risk than their male counterparts. Younger age is more frequently associated with depression, though older individuals with psoriasis can still be affected. Learn more about the prognosis of psoriasis. Pruritus is one of the main symptoms of plaque psoriasis. Although it varies in intensity, this symptom should not be disregarded owing to its significant impact on mental health. Anxiety and depression are linked to plaque psoriasis; these psychological comorbidities can increase the frequency and severity of pruritus, which results in an increased tendency to scratch; conversely, the increased pruritus and scratching also worsens anxiety and depression. It is estimated that 40% of patients with plaque psoriasis experience nail involvement. Further, nail involvement has been linked to "significant psychological distress, including anxiety and depression." Though any severity of skin pain can be linked to psychosocial burden in patients with chronic dermatological disorders such as plaque psoriasis, data have shown that patient-reported skin pain is usually of "moderate intensity" when HRQOL is negatively affected. Learn more about the signs and symptoms of plaque psoriasis. Psychosocial interventions have been shown to improve DLQI scores in patients with psoriasis. Specifically, the addition of mindfulness therapy to treatment as usual for psoriasis has been found to improve DLQI the most compared with other studied interventions (treatment as usual alone, psoriasis and lifestyle education, and online-based management). Cognitive-behavioral therapy in conjunction with pharmacological therapy has also been shown to improve psychosocial and disease-related symptoms. This result is most likely owing to stress as an identified trigger for psoriasis flares and decreased DLQI scores, with mindfulness therapy aiming to reduce stress and therefore flares. This is consistent with another recent review finding improvement in both disease severity and DLQI scores with various forms of mindfulness intervention. However, cognitive-behavioral therapy and treatment as usual were most effective for the other outcome measures, including anxiety, depression, and treatment adherence; mindfulness therapy was the least effective intervention for adherence. Education regarding psoriasis and lifestyle management that can help with symptoms was shown to improve HRQOL. Learn more about the treatment of psoriasis. Biologic therapy has been shown to effectively treat depression symptoms in the setting of psoriasis. Other therapeutic approaches that are effective for depression symptoms in psoriasis were conventional systemic therapy and phototherapy. Taken together, evidence supports the theory that improved skin disease is associated with improved psychiatric disease. Patients with psoriasis have a higher prevalence of hypertension. Beta-blockers in this setting can worsen psoriasis, which can negatively affect depression symptoms. Overall, evidence of a link between depression symptoms and beta-blocker use is mixed. Some psychotropic medications can cause flares in skin disease, including lithium, fluoxetine, and bupropion; these agents should therefore be prescribed with caution in this population. Similarly, the link between depression symptoms and psychotropic medication use is inconsistent. Though certain phosphodiesterase 4 inhibitors can improve psoriasis symptoms and can improve quality of life, data indicate that they can worsen depression symptoms. Learn more about the treatment of psoriasis. Editor's Note: This article was created using several editorial tools, including generative AI models, as part of the process. Human review and editing of this content were performed prior to publication.
